Company
Headquarters: Shanghai, China
Employees: 1,308
CEO: Dr. Xiucai Liu
CN¥36.66 Billion
CNY as of Jan. 1, 2026
US$5.23 Billion
| Company | Market Cap (USD) |
|---|---|
| Air Liquide SA | $108.08 B |
| Shin-Etsu Chemical Co Ltd | $56.20 B |
| Air Products and Chemicals, Inc. | $55.75 B |
| BASF SE | $46.95 B |
| Saudi Basic Industries Corp | $41.12 B |
| Company | Market Cap (USD) |
|---|---|
| Linde | $201.21 B |
| BHP | $151.21 B |
| Zijin Mining Group Co Ltd | $134.18 B |
| Rio Tinto | $131.23 B |
| Southern Copper Corporation | $121.79 B |
Cathay Biotech Inc. engages in the production and sale of bio-based polyamide, bio-based DN5, long chain dibasic acids, and biobutanol. The company is headquartered in Shanghai, China.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | CN¥3.29 B |
| EBITDA | CN¥747.8 M |
| Gross Profit TTM | CN¥1.01 B |
| Profit Margin | 18.08% |
| Operating Margin | 29.94% |
| Quarterly Revenue Growth | 13.40% |
Cathay Biotech, Inc. has the following listings and related stock indices.
Stock: SSE: 688065 wb_incandescent